The Africa Center for Disease Control (AfricaCDC) has explained that the Johnson and Johnson (J&J) vaccine was chosen for the continent because ‘it is a single shot vaccine, with a long shelf-life and partly manufactured on the African continent’. “First of all, as a single-shot vaccine, it is easier and cheaper to administer; second, the vaccine has a long shelf-life and favourable storage conditions. Last, but not least, the vaccine is partly manufactured on the African continent, with fill-finish activities taking place in South Africa”, according to Africa CDC Representative, Dr…
Read More